Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X:
“Good to see Christina Poh (fellow Fred Hutch faculty) here on the podium to teach us about CLL here at Binaytara Foundation’s BTFHem25 in Portland!
Jealous that you guys have venetoclax as an FDA-approved drug while we don’t yet in myeloma.”
